Innovair Indications/Uses


Full Prescribing Info
Regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting β2-agonist) is appropriate: Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting β2-agonist or patients already adequately controlled on both inhaled corticosteroids and long-acting β2-agonists.
Note: Innovair is not appropriate for treatment of acute asthma attacks.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in